William Vincent (Bill) is an accomplished biotechnology executive and entrepreneur with more than 35 years of leadership experience across the pharmaceutical, biotechnology, and healthcare industries. He is best known as the founder and former CEO of Genezen, a cell and gene therapy manufacturing company that he grew from a startup into a nationally recognized organization with more than 300 employees and over $100 million in annual revenue. Throughout his career, Bill has led organizations spanning pharmaceutical manufacturing, biotechnology, medical devices, and emerging healthcare technologies. Prior to Genezen, he served as President and CEO of Rimedion, a gene therapy company focused on treatments for rare diseases and has advised and served on the boards of numerous life sciences companies. Bill holds bachelor's degrees in microbiology and biochemistry and an MBA from the University of Texas at Austin.

Bill brings extensive leadership experience in the pharmaceutical and biotechnology industries, including a strong track record of growing organizations, developing strategic partnerships, advancing business development efforts, and building high-performing teams.